Cargando…

Clinical Efficacy and Parameters Affecting the Response to Dulaglutide Treatment in Patients with Type 2 Diabetes: A Retrospective, Real-World Data Study

INTRODUCTION: This study aimed to investigate the efficacy and clinical factors affecting the glycemic response to dulaglutide in type 2 diabetes (T2D) in a real-world clinical setting. METHODS: We conducted a retrospective study of 234 patients at the Asan Medical Center, Republic of Korea, who had...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Jee Hee, Cho, Yun Kyung, Lee, Jiwoo, Kim, Hwi Seung, Kang, Yu Mi, Jung, Chang Hee, Park, Joong-Yeol, Lee, Woo Je
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612352/ https://www.ncbi.nlm.nih.gov/pubmed/31240562 http://dx.doi.org/10.1007/s13300-019-0658-7

Ejemplares similares

Dulaglutide as an Add-on to Insulin in Type 2 Diabetes; Clinical Efficacy and Parameters Affecting the Response in Real-World Practice
por: Lee, Jiwoo, et al.
Publicado: (2019)

Dulaglutide as an Effective Replacement for Prandial Insulin in Kidney Transplant Recipients with Type 2 Diabetes Mellitus: A Retrospective Review
por: Kim, Hwi Seung, et al.
Publicado: (2021)

Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study
por: Kim, Hwi Seung, et al.
Publicado: (2022)

Clinical Efficacy of Quadruple Oral Therapy for Type 2 Diabetes in Real-World Practice: A Retrospective Observational Study
por: Cho, Yun Kyung, et al.
Publicado: (2020)

Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes
por: Cho, Yun Kyung, et al.
Publicado: (2019)

Metabolic health is a determining factor for incident colorectal cancer in the obese population: A nationwide population‐based cohort study
por: Cho, Yun Kyung, et al.
Publicado: (2020)

Differential Effect of Metabolic Health and Obesity on Incident Heart Failure: A Nationwide Population-Based Cohort Study
por: Kim, Hwi Seung, et al.
Publicado: (2021)

The risk of Alzheimer’s disease according to dynamic changes in metabolic health and obesity: a nationwide population-based cohort study
por: Cho, Yun Kyung, et al.
Publicado: (2021)

The Impact of NAFLD and Waist Circumference Changes on Diabetes Development in Prediabetes Subjects
por: Lee, Jiwoo, et al.
Publicado: (2019)

Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study
por: Kim, Hwi Seung, et al.
Publicado: (2022)

Real-World Efficacy and Safety of Dulaglutide in Korean Patients with Type 2 Diabetes Mellitus: A Retrospective Study in a Tertiary Referral Center
por: Yoon, Jee Hee, et al.
Publicado: (2021)

Prognostic Value of Triglyceride and Glucose Index for Incident Type 2 Diabetes beyond Metabolic Health and Obesity
por: Kim, Hwi Seung, et al.
Publicado: (2021)

Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials
por: Kang, Yu Mi, et al.
Publicado: (2019)

The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification
por: Cho, Yun Kyung, et al.
Publicado: (2018)

Triglyceride–Glucose Index Predicts Cardiovascular Outcome in Metabolically Unhealthy Obese Population: A Nationwide Population-Based Cohort Study
por: Cho, Yun Kyung, et al.
Publicado: (2022)

Implications of metabolic health status and obesity on the risk of kidney cancer: A nationwide population-based cohort study
por: Cho, Yun Kyung, et al.
Publicado: (2022)

Response: Triglyceride-Glucose Index Predicts Cardiovascular Outcome in Metabolically Unhealthy Obese Population: A Nationwide Population-Based Cohort Study (J Obes Metab Syndr 2022;31:178-86)
por: Cho, Yun Kyung, et al.
Publicado: (2023)

Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease
por: Lee, Jiwoo, et al.
Publicado: (2020)

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography
por: Kim, Hwi Seung, et al.
Publicado: (2023)

Triglyceride Glucose-Waist Circumference Better Predicts Coronary Calcium Progression Compared with Other Indices of Insulin Resistance: A Longitudinal Observational Study
por: Cho, Yun Kyung, et al.
Publicado: (2020)

Free Versus Fixed-Ratio Combination of Basal Insulin and GLP-1 Receptor Agonists in Type 2 Diabetes Uncontrolled With GLP-1 Receptor Agonists: A Systematic Review and Indirect Treatment Comparison
por: Jung, Han Na, et al.
Publicado: (2022)

Triglyceride-Glucose Index Is a Useful Marker for Predicting Future Cardiovascular Disease and Mortality in Young Korean Adults: A Nationwide Population-Based Cohort Study
por: Cho, Yun Kyung, et al.
Publicado: (2022)

Comparison between sodium–glucose cotransporter 2 inhibitors and pioglitazone as additions to insulin therapy in type 2 diabetes patients: A systematic review with an indirect comparison meta‐analysis
por: Cho, Yun Kyung, et al.
Publicado: (2018)

Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects
por: Kim, Hwi Seung, et al.
Publicado: (2021)

Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study
por: Tanaka, Kenichi, et al.
Publicado: (2022)

Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study
por: Cho, Yun Kyung, et al.
Publicado: (2023)

Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
por: Robinson, Susan, et al.
Publicado: (2020)

Mortality and causes of death in a national sample of type 2 diabetic patients in Korea from 2002 to 2013
por: Kang, Yu Mi, et al.
Publicado: (2016)

Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658–62)
por: Kim, Hwi Seung, et al.
Publicado: (2022)

Real-World Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist, Dulaglutide, on Metabolic Parameters in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study
por: Katsuyama, Hisayuki, et al.
Publicado: (2023)

Empagliflozin and Dulaglutide are Effective against Obesity-induced Airway Hyperresponsiveness and Fibrosis in A Murine Model
por: Park, Hye Jung, et al.
Publicado: (2019)

Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
por: Kang, Yu Mi, et al.
Publicado: (2017)

Effect of once-weekly dulaglutide on renal function in patients with chronic kidney disease
por: Kim, Sungmin, et al.
Publicado: (2022)

Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study
por: Jain, Akshay B., et al.
Publicado: (2020)

Comparing Real-World Effectiveness of Dulaglutide and Insulin as the First Injectable for Patients with Type 2 Diabetes: An Australian Single-Site Retrospective Chart Review
por: Houssarini, Jared A., et al.
Publicado: (2021)

Exacerbation of atrial fibrillation related to dulaglutide use
por: Lee, Jayden, et al.
Publicado: (2021)

Liraglutide and Dulaglutide therapy in addition to SGLT-2 inhibitor and metformin treatment in Indian type 2 diabetics: a real world retrospective observational study
por: Ghosal, S., et al.
Publicado: (2018)

Clinical Characteristics Associated with Adherence and Persistence in Patients with Type 2 Diabetes Mellitus Treated with Dulaglutide
por: Lee, David Seung U., et al.
Publicado: (2023)

Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study
por: Kim, Si Hyoung, et al.
Publicado: (2022)

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics
por: García-Pérez, Luis-Emilio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dgioulsagbcrt01fnhf3odv207